Andere talen Intellipharmaceutics International Inc.

Aandelen

IPCI.H

CA4581733090

Vertraagde tijd Toronto S.E. Andere beurzen 17:00:00 21-03-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,08 ^CAD	-.--%		-11,11%	+6,67%

2023	Intellipharmaceutics International Inc. rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 31 augustus 2023	CI
2023	Intellipharmaceutics International Inc. rapporteert resultaten voor het tweede kwartaal en de zes maanden eindigend op 31 mei 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Canadian Investment Regulatory Organization Trading Halt - IPCI	06/03
IntelliPharmaCeutics International Receives Conditional Approval For TSXV Listing	03/01
Intellipharmaceutics: Fiscal Q3 Earnings Snapshot	16-10-23
Intellipharmaceutics International : MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE AND NINE MONTHS ENDED AUGUST 31, 2023 - Form 6-K	16-10-23
Intellipharmaceutics International Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023	16-10-23
Intellipharmaceutics International : Reports Director Election Results - Form 6-K	06-10-23
Intellipharmaceutics International : Appointment of Proxyholder - Form 6-K	06-10-23
Intellipharmaceutics International : MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS - Form 6-K	26-09-23
Intellipharmaceutics Announces Second Quarter 2023 Results	17-07-23
Intellipharmaceutics International Inc. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2023	14-07-23
Intellipharmaceutics: Fiscal Q2 Earnings Snapshot	14-07-23
IntelliPharmaCeutics International Fiscal Q2 Loss Narrows on Higher Revenue	14-07-23
Canadian Investment Regulatory Organization Trade Resumption - IPCI	08-06-23
Intellipharmaceutics: Fiscal Q4 Earnings Snapshot	06-06-23
Intellipharmaceutics: Fiscal Q1 Earnings Snapshot	06-06-23
Intellipharmaceutics International Narrows Fiscal Q1 Loss, Revenue Rises	06-06-23
Intellipharmaceutics International Inc. Brief: Recorded net loss for Q1 of US$355,738 or $0.01 per common shar	06-06-23
Intellipharmaceutics Announces Fiscal Year 2022 and First Quarter 2023 Results	06-06-23
Intellipharmaceutics International Inc. Auditor Raises 'Going Concern' Doubt	05-06-23
Intellipharmaceutics International Inc. Reports Earnings Results for the First Quarter Ended February 28, 2023	05-06-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Intellipharmaceutics International Inc.

Aandelen

IPCI.H

CA4581733090

Andere talen

Filters